Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 1 von 621
Metabolism, clinical and experimental, 2021-05, Vol.118, p.154732-154732, Article 154732
2021
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study
Ist Teil von
  • Metabolism, clinical and experimental, 2021-05, Vol.118, p.154732-154732, Article 154732
Ort / Verlag
United States: Elsevier Inc
Erscheinungsjahr
2021
Quelle
MEDLINE
Beschreibungen/Notizen
  • Recent studies suggested obesity to be a possible risk factor for COVID-19 disease in the wake of the coronavirus (SARS-CoV-2) infection. However, the causality and especially the role of body fat distribution in this context is still unclear. Thus, using a univariable as well as multivariable two-sample Mendelian randomization (MR) approach, we investigated for the first time the causal impact of body composition on the susceptibility and severity of COVID-19. As indicators of overall and abdominal obesity we considered the measures body mass index (BMI), waist circumference (WC), and trunk fat ratio (TFR). Summary statistics of genome-wide association studies (GWASs) for these body composition measures were drawn from the GIANT consortium and UK Biobank, while for susceptibility and severity due to COVID-19 disease data from the COVID-19 Host Genetics Initiative was used. For the COVID-19 cohort neither age nor gender was available. Total and direct causal effect estimates were calculated using Single Nucleotide Polymorphisms (SNPs), sensitivity analyses were done applying several robust MR techniques and mediation effects of type 2 diabetes (T2D) and cardiovascular diseases (CVD) were investigated within multivariable MR analyses. Genetically predicted BMI was strongly associated with both, susceptibility (OR = 1.31 per 1 SD increase; 95% CI: 1.15–1.50; P-value = 7.3·10−5) and hospitalization (OR = 1.62 per 1 SD increase; 95% CI: 1.33–1.99; P-value = 2.8·10−6) even after adjustment for genetically predicted visceral obesity traits. These associations were neither mediated substantially by T2D nor by CVD. Finally, total but not direct effects of visceral body fat on outcomes could be detected. This study provides strong evidence for a causal impact of overall obesity on the susceptibility and severity of COVID-19 disease. The impact of abdominal obesity was weaker and disappeared after adjustment for BMI. Therefore, obese people should be regarded as a high-risk group. Future research is necessary to investigate the underlying mechanisms linking obesity with COVID-19. •Overall fat content has a causal impact on the susceptibility and severity of COVID-19.•These associations were neither mediated substantially by T2D nor by CVD.•Visceral fat content has no significant direct effect on the COVID-19 outcomes.
Sprache
Englisch
Identifikatoren
ISSN: 0026-0495, 1532-8600
eISSN: 1532-8600
DOI: 10.1016/j.metabol.2021.154732
Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7900753

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX